SARS-CoV-2 causes brain inflammation and induces Lewy body formation in macaques
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
SARS-CoV-2 may cause acute respiratory disease, but the infection can also initiate neurological symptoms. Here we show that SARS-CoV-2 infection causes brain inflammation in the macaque model. An increased metabolic activity in the pituitary gland of two macaques was observed by longitudinal positron emission tomography-computed tomography (PET-CT). Post-mortem analysis demonstrated infiltration of T-cells and activated microglia in the brain, and viral RNA was detected in brain tissues from one animal. We observed Lewy bodies in brains of all rhesus macaques. These data emphasize the virus’ capability to induce neuropathology in this nonhuman primate model for SARS-CoV-2 infection. As in humans, Lewy body formation is an indication for the development of Parkinson’s disease, this data represents a warning for potential long-term neurological effects after SARS-CoV-2 infection.
Teaser
SARS-CoV-2 causes brain inflammation and Lewy bodies, a hallmark for Parkinson, after an asymptomatic infection in macaques.
Article activity feed
-
-
SciScore for 10.1101/2021.02.23.432474: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: The research protocol was approved by an independent animal ethics committee (DEC), as well as BPRC’s institutional animal welfare body (IvD). Randomization not detected. Blinding The counting of cells was performed in a blind matter. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication Authentication: Hematoxyline-eosine (HE) staining was used for general morphology. Table 2: Resources
Antibodies Sentences Resources Sections were stained with virus antibody staining for virus detection and immunohistochemistry for immune reaction such as T-cell staining (CD3), B-cell staining (CD20), MHC-II cell staining (HLA-DR). CD20suggested…SciScore for 10.1101/2021.02.23.432474: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: The research protocol was approved by an independent animal ethics committee (DEC), as well as BPRC’s institutional animal welfare body (IvD). Randomization not detected. Blinding The counting of cells was performed in a blind matter. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication Authentication: Hematoxyline-eosine (HE) staining was used for general morphology. Table 2: Resources
Antibodies Sentences Resources Sections were stained with virus antibody staining for virus detection and immunohistochemistry for immune reaction such as T-cell staining (CD3), B-cell staining (CD20), MHC-II cell staining (HLA-DR). CD20suggested: NoneHLA-DRsuggested: NoneImmunohistochemistry: The optimal concentration was determined for each antibody: CD3 (polyclonal rabbit – anti-human CD3 IgG, cat. no. A045201-2 CD3suggested: Noneanti-human CD3 IgGsuggested: NoneSoftware and Algorithms Sentences Resources All macaques were mature, outbred animals, purpose-bred and socially housed at the BPRC. BPRCsuggested: None2, Agilent Technologies), 1:150. Agilent Technologiessuggested: (Agilent Technologies, RRID:SCR_013575)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-